Document type
ArticlePublication date
All rights reserved
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/207000
The microphthalmia-associated transcription factor is involved in gastrointestinal stromal tumor growth
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Gastrointestinal stromal tumors (GISTs) are the most common neoplasms of mesenchymal origin, and most of them emerge due to the oncogenic activation of KIT or PDGFRA receptors. Despite their relevance in GIST oncogenesis, critical intermediates mediating the KIT/PDGFRA transforming program remain mostly unknown. Previously, we found that the adaptor molecule SH3BP2 was involved in GIST cell survival, likely due to the co-regulation of the expression of KIT and Microphthalmia-associated transcription factor (MITF). Remarkably, MITF reconstitution restored KIT expression levels in SH3BP2 silenced cells and restored cell viability. This study aimed to analyze MITF as a novel driver of KIT transforming program in GIST. Firstly, MITF isoforms were characterized in GIST cell lines and GIST patients' samples. MITF silencing decreases cell viability and increases apoptosis in GIST cell lines irrespective of the type of KIT primary or secondary mutation. Additionally, MITF silencing leads to cell cycle arrest and impaired tumor growth in vivo. Interestingly, MITF silencing also affects ETV1 expression, a linage survival factor in GIST that promotes tumorigenesis and is directly regulated by KIT signaling. Altogether, these results point to MITF as a key target of KIT/PDGFRA oncogenic signaling for GIST survival and tumor growth.
Subject (English)
Citation
Citation
PROAÑO PÉREZ, Elizabeth, et al. The microphthalmia-associated transcription factor is involved in gastrointestinal stromal tumor growth. Cancer Gene Therapy. 2022. Vol. 30, num. 2, pags. 245-255. ISSN 0929-1903. [consulted: 19 of August of 2026]. Available at: https://hdl.handle.net/2445/207000